TBA Law Blog


Posted by: Paul Burch on May 18, 2023

The U.S. Court of Appeals for the 5th Circuit heard oral arguments Wednesday in the case Alliance for Hippocratic Medicine v. FDA, which challenges the Food and Drug Administration's 2000 approval of mifepristone, a commonly used drug for abortions and miscarriages, reported Roll Call. The three judge panel expressed concern about telemedicine and the lack of oversight when prescribing and dispensing the drug by mail. The pharmaceutical industry has warned that a court ruling challenging the FDA’s authority to regulate drugs would be unprecedented and could undermine the development and approval of new medications.